What is Morgan Stanley's price target for IIIV?

Morgan Stanley's latest stated price target for i3 Verticals Inc. (IIIV) is $26.50, from its action on Feb 10, 2022.

What is Morgan Stanley's rating on IIIV?

Morgan Stanley rates IIIV Equal-Weight, a neutral rating, as of Feb 10, 2022.

When did Morgan Stanley last change its view on IIIV?

On Feb 10, 2022, Morgan Stanley raises its price target to $26.50 from $24.50, keeps Equal-Weight.

Morgan Stanley IIIV price target and rating history

Morgan Stanley rates i3 Verticals Inc. (IIIV) Equal-Weight with a $26.50 price target, as of its latest action on Feb 10, 2022. It has published 3 rating actions on IIIV since July 2021, including 0 upgrades and 0 downgrades.

Current rating: Equal-Weight
Price target: $26.50
Median target, all firms: Too few
Actions on IIIV: 3

Morgan Stanley price target on IIIV

Morgan Stanley price target on IIIV, each point a stated target, July 2021 to February 2022.

Every Morgan Stanley rating on IIIV

Feb 10, 2022
ReiterateMorgan Stanley raises its price target to $26.50 from $24.50, keeps Equal-Weight
Nov 19, 2021
ReiterateMorgan Stanley cuts its price target to $24.50 from $34, keeps Equal-Weight
Jul 26, 2021
InitiateMorgan Stanley starts coverage at Equal-Weight, price target $34

Questions about Morgan Stanley and IIIV

What is Morgan Stanley's price target for IIIV?: Morgan Stanley's latest stated price target for i3 Verticals Inc. (IIIV) is $26.50, from its action on Feb 10, 2022.
What is Morgan Stanley's rating on IIIV?: Morgan Stanley rates IIIV Equal-Weight, a neutral rating, as of Feb 10, 2022.
When did Morgan Stanley last change its view on IIIV?: On Feb 10, 2022, Morgan Stanley raises its price target to $26.50 from $24.50, keeps Equal-Weight.

More IIIV rating histories

KeyBanc Capital Markets3

All Morgan Stanley ratings IIIV news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.